This Comment By Chinese Embassy On Indian Medicines Has Sparked Speculation Ahead Of Likely Modi-Xi Meet
PLI Scheme Success: India Reduces Dependence On China, Manufacturing Of 38 Active Pharma Ingredients Commenced In Past 18 Months
PLI Scheme For API,KSM In Pharmaceutical Sector: First Trance Of Incentives Worth Rs 165.74 Crore Released To 4 Firms Including Dr Reddy's Lab, Biocon
Ami Organics Limited Looking To Raise Rs 570 crore Through IPO
Glenmark Life Sciences IPO: Should You Subscribe? Strong Player In APIs With Focus On Contract Development and Manufacturing
Atmanirbhar Pharma Sector: Govt Clears 19 Applications With Committed Investment Of Rs 4,623 Crore Under PLI Scheme
Modi Govt Unveils 3 Production Incentive Schemes Worth Rs 12,000 cr To Boost Local Manufacturing Of API, Medical Devices And Bulk Drugs
Coronavirus Pandemic: Govt Fast-Tracks Environmental Clearance Process To Companies To Curb Drug Shortage
